Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials. [electronic resource]
Producer: 20210601Description: 1753466620905278 p. digitalISSN:- 1753-4666
- Administration, Inhalation
- Adrenal Cortex Hormones -- administration & dosage
- Adrenergic beta-Agonists -- administration & dosage
- Aged
- Benzamides -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Carbamates -- administration & dosage
- Clinical Trials, Phase III as Topic
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Forced Expiratory Volume
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Nebulizers and Vaporizers
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Randomized Controlled Trials as Topic
- Recovery of Function
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.